106 results on '"Sanchez-Guijo, F."'
Search Results
2. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
3. Mesenchymal Stem/Stromal Cells: TRANSCRIPTOMIC STUDY OF THE IMMUNOMODULATORY PROPERTIES OF TLR3-PRIMED MESENCHYMAL STEM CELLS ISOLATED FROM HUMAN BONE MARROW
4. Immunotherapy: HIGH INCIDENCE OF CYTOPENIAS AFTER COMMERCIAL CAR-T CELL THERAPY IN A REAL-WORLD SETTING: UTILITY OF THE CAR-HEMATOTOX INDEX
5. Síndromes mieloproliferativos
6. Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome
7. Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction
8. GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study
9. P837: ELTROMBOPAG (EPAG) INDUCES HEMATOLOGIC RESPONSES FOR PATIENTS WITH POST-ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT POOR GRAFT FUNCTION (POST-ALLO HSCT PGF): RESULTS OF THE ELTION STUDY IN SPAIN
10. P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL
11. Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
12. P36 - Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: MESENCHYMAL STROMAL CELLS MAY ENHANCE RESIDUAL HEALTHY HAEMATOPOIESIS IN LOW-RISK MDS PATIENTS
13. Human bone marrow mesenchymal stromal cell-derived extracellular vesicles modified by enzymatic exofucosylation prevent acute graft-versus-host disease progression
14. LONG-TERM FOLLOW-UP OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA PATIENTS: PH-P534
15. Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
16. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome
17. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases
18. Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model: Prognostication in myelofibrosis
19. Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research
20. Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes
21. Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers
22. Intrabone marrow transplantation of cord blood cells is associated with better platelet recovery and decreased acute GvHD as compared with intravenous transplantation: an EUROCORD matched-paired analysis: O106
23. Multicenter, Open-Label, Single Arm, Phase II Exploratory Study to Evaluate the Effect of a One-Year Consolidation Treatment with Ponatinib 15 Mg on Treatment Free-Remission Rate in Patients with Philadelphia-Positive Chronic Myeloid Leukemia, Who Had Previously Achieved a Deep Molecular Response with Imatinib (PonaZero_study)
24. PRELIMINARY RESULTS OF THE RELMC-NOVA STUDY: KINETICS OF THE MOLECULAR RESPONSE IN PATIENTS RECEIVE DIAGNOSTICS OF LMC-FC TREATED WITH ITKS IN 1 LINE
25. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic haematopoietic stem cell transplantation
26. Manufacturing mesenchymal stromal cells for the treatment of graft-versus-host disease
27. SUSPENSION OF TREATMENT WITH BCR-ABL INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE WITHIN OF THE CLINICAL ASSISTANCE PRACTICE: SPANISH EXPERIENCE IN A TOTAL OF 236 CASES
28. PS1186 CURRENT DOSE RECOMMENDATIONS FOR PONATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS CAN DIMINISH ADVERSE EVENTS WHILE MAINTAINING EFFICACY
29. Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation
30. C013 Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease
31. Results of a prospective phase II trial with ofatumumab as part of reduced intensity conditioning regimen in high-risk non-Hodgkin B lymphoma patients: A GELTAMO trial
32. Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation
33. 201 - Mesenchymal Stem/Stromal Cells: TRANSCRIPTOMIC STUDY OF THE IMMUNOMODULATORY PROPERTIES OF TLR3-PRIMED MESENCHYMAL STEM CELLS ISOLATED FROM HUMAN BONE MARROW.
34. PSY9 - Second-Line Treatment for Steroid-Refractory Graft-Versus-Host Disease with Mesenchymal Stromal Cells. A Conceptual Disease Model
35. 282 - Iron Overload Increases Oxidative Stress and Decreases Clonogenic Capacity of Cells in MDS Patients: Can be Restored after Deferasirox Treatment?
36. 196 - Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients
37. Effects of MSC Coadministration and Route of Delivery on Cord Blood Hematopoietic Stem Cell Engraftment
38. Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
39. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients
40. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial
41. 29 MICROVESICLES/EXOSOMES DERIVED FROM BONE MARROW MESENCHYMAL STROMAL CELLS (MSC) ARE INVOLVED IN THE INTERCELLULAR COMMUNICATION BETWEEN HEMATOPOIETIC CELLS AND BM MICROENVIRONMENT IN MDS PATIENTS
42. Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population
43. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes
44. Feasibility of tyrosine kinase inhibitor (TKI) treatment in older patients with Ph + chronic myeloid leukemia (CML): A Spanish group of CML (GELMC) retrospective study
45. Intrabone marrow transplantation of cord blood cells is associated with better platelet recovery and decreased acute GvHD as compared with intravenous transplantation: an EUROCORD matched-paired analysis
46. EFFICACY OF SWITCHING TO DASATINIB IN CHRONIC MYELOID PATIENTS WITH LATE WARNING RESPONSES TO IMATINIB. STUDY OF THE ASSOCIATION OF RESPONSE TO DASATINIB TO IMMUNOLOGIC STATUS
47. INTRA-BONE MARROW (IBM) TRANSPLANT OF CORD BLOOD CELLS IS ASSOCIATED WITH BETTER ENGRAFTMENT, FASTER PLATELET RECOVERY AND LESS SEVERE AGVHD AS COMPARED WITH INTRAVENOUS ADMINISTRATION. AN EUROCORD MATCHED PAIRED ANALYSIS
48. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
49. Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT).
50. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.